Rhenman & Partners Asset Management Ab Kura Oncology, Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 195,000 shares of KURA stock, worth $1.09 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
195,000
Previous 314,526
38.0%
Holding current value
$1.09 Million
Previous $2.74 Million
53.01%
% of portfolio
0.15%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$43.5 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$41.7 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$39.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$36.9 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$27.8 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $375M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...